首页> 外文会议>World biomaterials congress >An organic chemistry approach to the surface modification of biomedical devices to limit bacterial adhesion and blood coagulation
【24h】

An organic chemistry approach to the surface modification of biomedical devices to limit bacterial adhesion and blood coagulation

机译:生物医学装置表面改性的有机化学方法,限制细菌粘附和血液凝固

获取原文

摘要

Introduction: A wide range of biomedical devices have to be implanted in the body and put in contact with blood. Most of the time, they are made of polymers such as polydimethylsiloxane or polyurethane having a hydrophobic surface. Two major problems are associated with the implantation of this kind of devices in the bloodstream: infection due to the adhesion of bacteria to the surface of the device and the formation of a biofilm; blood coagulation when blood proteins adsorb on the surface, as a starting point to the blood coagulation cascade that can lead to the adhesion of platelets and the formation of a blood clot in catheters for example. To avoid these complications, various strategies have been used: adsorption of anticoagulant polymers of the surface, addition of a surface modifying molecule to the polymer blend or chemical modification of the surface by different ways. However, on the market today there is no strategy that allows to improve hemocompatibility and to reduce bacterial adhesion in the same time with polyurethane implants by covalent binding of molecules or polymers at the surface. Our group previously proved that covalent grafting of methylcellulose onto silicone implants allowed a significant reduction of bacterial adhesion and blood coagulation in vitro and in vivo. We are interested in finding a strategy that would allow us to modify polyurethane surfaces in a single step, using soft reaction conditions, to lead to similar antiadhesive properties. Materials and Method: To better approach the chemical reactivity of polyurethane surfaces, model urethane molecules were synthesized and a screening of organic chemistry reactions was performed to modify these urethanes. Successful reaction conditions were scaled up to modify polyurethane device surfaces in order to graft bioactive molecules or polymers that would confer the desired properties to the surface. After modification, the modified surfaces were tested and analyzed ensure the efficiency of the modification. Surface analysis techniques (contact angle, ATR-FTIR, XPS, TOF-SIMS) were used to characterize the modified surface. Biological assays such as bacterial adhesion, cell adhesion, blood protein adsorption and blood coagulation were done to check the antiadhesive properties of modified surfaces. Results and Discussion: The successful reactions were used to modify polyurethane surfaces and confer them excellent antiadhesive properties. Hydrophilic surfaces were created as verified by contact angle measurements. Bacterial adhesion was reduced by 100-1000 fold depending on the polymer and reaction, and cell adhesion was significantly reduced. Blood protein adsorption was also significantly reduced. The modified surfaces were stable over time in air or aqueous media. Conclusion: A screening of reactions allow us to identify several reactions to graft polymers (PEG, polysaccharides…) and have efficient surface modification of polyurethane. The modified surfaces are hydrophilic and show excellent antiadhesive properties towards bacteria, blood proteins and cells. We have developped a very promising system to allow a one-step modification of polyurethane medical devices, using non toxic reagents and covalent binding of the grafted polymer.
机译:简介:必须植入各种生物医学装置,并与血液接触。大多数情况下,它们由聚合物制成,例如聚二甲基硅氧烷或具有疏水表面的聚氨酯。两个主要问题与血液中这种装置的植入有关:​​感染由于细菌的粘附到装置表面和生物膜的形成;血液凝血当血液蛋白吸附在表面上时,作为血液凝固级联的起点,其可以导致血小板的粘附和导管中的血凝块的形成。为了避免这些并发症,已经使用了各种策略:通过不同方式对表面的抗凝血聚合物的吸附,将表面改性分子添加到聚合物共混物或表面的化学改性。然而,在今天的市场上,没有策略,可以通过在表面上的分子或聚合物的共价结合,同时用聚氨酯植入物同时降低细菌粘合性。我们的小组先前证明,将甲基纤维素的共价接枝在硅氧烷植入物上允许在体外和体内显着降低细菌粘附和血液凝固。我们有兴趣找到一种允许我们在单一步骤中使用软反应条件来修饰聚氨酯表面的策略,以导致类似的抗粘附性能。材料和方法:为了更好地接近聚氨酯表面的化学反应性,合成模型聚氨酯分子,进行有机化学反应的筛选以改性这些氨基甲酸酯。缩放成功的反应条件以修饰聚氨酯器件表面,以使接枝生物活性分子或聚合物将所需性质赋予表面。修改后,测试改进的表面并分析确保改性的效率。表面分析技术(接触角,ATR-FTIR,XPS,TOF-SIMS)用于表征改性表面。进行诸如细菌粘附,细胞粘附,血液蛋白质吸附和血液凝固的生物测定以检查改性表面的抗粘附性。结果与讨论:使用成功的反应来改性聚氨酯表面并赋予它们优异的抗粘附性能。通过接触角测量的验证产生亲水性表面。根据聚合物和反应,细菌粘附减少100-1000倍,并且细胞粘附显着降低。血液蛋白吸附也显着降低。在空气或水性介质中,改性表面随时间稳定。结论:反应的筛选允许我们鉴定对移植聚合物(PEG,多糖...)的几种反应,并具有聚氨酯的有效表面改性。改性表面是亲水的,并朝向细菌,血液蛋白和细胞显示出优异的抗粘附性。我们已经开发出一种非常有前途的系统,以允许使用非有毒试剂和接枝聚合物的共价结合进行聚氨酯医疗装置的一步改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号